- Home
- BWLP vs TVTX Comparison
BWLP vs TVTX Comparison
Compare BWLP & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- TVTX
- Stock Information
- Founded
- BWLP 1935
- TVTX 2008
- Country
- BWLP Singapore
- TVTX United States
- Employees
- BWLP N/A
- TVTX N/A
- Industry
- BWLP Marine Transportation
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- BWLP Consumer Discretionary
- TVTX Health Care
- Exchange
- BWLP Nasdaq
- TVTX Nasdaq
- Market Cap
- BWLP 1.8B
- TVTX 1.5B
- IPO Year
- BWLP N/A
- TVTX N/A
- Fundamental
- Price
- BWLP $12.01
- TVTX $19.46
- Analyst Decision
- BWLP
- TVTX Buy
- Analyst Count
- BWLP 0
- TVTX 12
- Target Price
- BWLP N/A
- TVTX $24.58
- AVG Volume (30 Days)
- BWLP 518.8K
- TVTX 1.2M
- Earning Date
- BWLP 01-01-0001
- TVTX 02-13-2025
- Dividend Yield
- BWLP 13.99%
- TVTX N/A
- EPS Growth
- BWLP 17.09
- TVTX N/A
- EPS
- BWLP 3.59
- TVTX N/A
- Revenue
- BWLP $3,601,810,000.00
- TVTX $203,447,000.00
- Revenue This Year
- BWLP N/A
- TVTX $62.37
- Revenue Next Year
- BWLP N/A
- TVTX $61.74
- P/E Ratio
- BWLP $3.95
- TVTX N/A
- Revenue Growth
- BWLP 38.21
- TVTX 57.08
- 52 Week Low
- BWLP $9.95
- TVTX $5.12
- 52 Week High
- BWLP $22.31
- TVTX $20.33
- Technical
- Relative Strength Index (RSI)
- BWLP 55.86
- TVTX 59.31
- Support Level
- BWLP $12.27
- TVTX $16.80
- Resistance Level
- BWLP $13.11
- TVTX $18.76
- Average True Range (ATR)
- BWLP 0.31
- TVTX 0.95
- MACD
- BWLP 0.17
- TVTX 0.09
- Stochastic Oscillator
- BWLP 64.88
- TVTX 89.86
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.